Takahiro Yoshida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer”.

Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer

Drug Delivery and Translational Research(2020)10.1007/s13346-020-00870-w

N/A

0DataRank · unranked

11 citations

Max Kates, Takahiro Yoshida, Taarika Babu, Umara Afzal, Pranjali Kanvinde +8 more

WITHDRAWN: Recombinant BCG overexpressing a STING agonist elicits trained immunity and improved antitumor efficacy in non-muscle invasive bladder cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.25.061531

N/A

0DataRank · unranked

6 citations

Monali Praharaj, Kara A. Lombardo, Takahiro Yoshida, Andrés Matoso, Alex S. Baras +9 more

RETRACTED ARTICLE: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer

Nature Communications(2022)10.1038/s41467-022-28509-z

N/A

0DataRank · unranked

98 citations

Monali Praharaj, Kara A. Lombardo, Takahiro Yoshida, Andrés Matoso, Alex S. Baras +11 more

Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.15.571740

N/A

0DataRank · unranked

6 citations

Monali Praharaj, Kara A. Lombardo, Takahiro Yoshida, Andrés Matoso, Alex S. Baras +10 more